Ronald M. Lindsay, Executive VP, R&D at SEQUENOM INC (SQNM), bought 100,000 shares at $2.93 ($299K) on 2012-08-01, disclosed to the SEC on 2012-08-02.
Open-market purchase of $299k SQNM by Executive VP, R&D. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.87 | 1,900 | $5K | 1.8% |
| 2 | $2.90 | 335 | $972 | 0.3% |
| 3 | $2.92 | 1,100 | $3K | 1.1% |
| 4 | $2.93 | 3,300 | $10K | 3.2% |
| 5 | $2.95 | 2,600 | $8K | 2.6% |
| 6 | $2.96 | 1,000 |
| $3K |
| 1.0% |
| 7 | $2.97 | 400 | $1K | 0.4% |
| 8 | $2.99 | 600 | $2K | 0.6% |
| 9 | $3.00 | 88,765 | $266K | 89.0% |
| Total | $2.99 avg | 100,000 | $299K | 100% |
| Filing → |
| SQNM | BUY | 2011-11-07 | $85K | — | Filing → |
| SQNM | BUY | 2011-03-11 | $111K | — | Filing → |
| ARQL | BUY | 2008-11-17 | $51K | — | Filing → |